chr16-85918628-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_002163.4(IRF8):​c.813C>T​(p.Phe271Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00397 in 1,608,418 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0036 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 25 hom. )

Consequence

IRF8
NM_002163.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.152

Publications

3 publications found
Variant links:
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
MIR6774 (HGNC:50202): (microRNA 6774) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 16-85918628-C-T is Benign according to our data. Variant chr16-85918628-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 542147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.152 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002163.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IRF8
NM_002163.4
MANE Select
c.813C>Tp.Phe271Phe
synonymous
Exon 7 of 9NP_002154.1Q02556
IRF8
NM_001363907.1
c.843C>Tp.Phe281Phe
synonymous
Exon 7 of 9NP_001350836.1
IRF8
NM_001363908.1
c.201C>Tp.Phe67Phe
synonymous
Exon 5 of 7NP_001350837.1H3BRT4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IRF8
ENST00000268638.10
TSL:1 MANE Select
c.813C>Tp.Phe271Phe
synonymous
Exon 7 of 9ENSP00000268638.4Q02556
IRF8
ENST00000564803.6
TSL:2
c.813C>Tp.Phe271Phe
synonymous
Exon 7 of 9ENSP00000456992.2Q02556
IRF8
ENST00000696887.1
c.813C>Tp.Phe271Phe
synonymous
Exon 7 of 9ENSP00000512953.1Q02556

Frequencies

GnomAD3 genomes
AF:
0.00356
AC:
542
AN:
152264
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0168
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00412
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00340
AC:
813
AN:
239020
AF XY:
0.00328
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00160
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000226
Gnomad FIN exome
AF:
0.0174
Gnomad NFE exome
AF:
0.00386
Gnomad OTH exome
AF:
0.00390
GnomAD4 exome
AF:
0.00402
AC:
5850
AN:
1456036
Hom.:
25
Cov.:
31
AF XY:
0.00397
AC XY:
2876
AN XY:
724628
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33456
American (AMR)
AF:
0.00175
AC:
78
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26090
East Asian (EAS)
AF:
0.000907
AC:
36
AN:
39686
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86216
European-Finnish (FIN)
AF:
0.0164
AC:
796
AN:
48538
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5642
European-Non Finnish (NFE)
AF:
0.00422
AC:
4692
AN:
1111496
Other (OTH)
AF:
0.00352
AC:
212
AN:
60240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
389
778
1167
1556
1945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00356
AC:
542
AN:
152382
Hom.:
2
Cov.:
33
AF XY:
0.00396
AC XY:
295
AN XY:
74522
show subpopulations
African (AFR)
AF:
0.000625
AC:
26
AN:
41590
American (AMR)
AF:
0.00333
AC:
51
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.0168
AC:
179
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00412
AC:
280
AN:
68034
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
32
64
95
127
159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00319
Hom.:
0
Bravo
AF:
0.00243
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00382
EpiControl
AF:
0.00267

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;C4751209:Immunodeficiency 32B (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
9.1
DANN
Benign
0.78
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147080359; hg19: chr16-85952234; COSMIC: COSV51897701; COSMIC: COSV51897701; API